Cargando…
The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica
INTRODUCTION: Midkine (MK), a heparin-binding growth factor, is involved in neurological diseases by mediating the inflammatory responses through enhancing the leukocyte migration. The present study assesses the serum concentration of this growth factor among newly developed Multiple Sclerosis (MS)...
Autores principales: | Moayednia, Milad, Dehghani, Leila, Safi, Amir, Shaygannejad, Vahid, Sohrabi, Karim, Rezvani, Majid, Akrami, Mohammad Reza, Soghrati, Mojgan, Aboutalebi, Mohammad Mahdi, Barzegar, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Neuroscience Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672672/ https://www.ncbi.nlm.nih.gov/pubmed/34925716 http://dx.doi.org/10.32598/bcn.12.2.1009.2 |
Ejemplares similares
-
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica
por: Chitsaz, Niloofar, et al.
Publicado: (2019) -
Screening neuromyelitis optica patients for COVID-19 infection
por: Mirmosayyeb, Omid, et al.
Publicado: (2020) -
Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS)
por: Mirmosayyeb, Omid, et al.
Publicado: (2021) -
COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Barzegar, Mahdi, et al.
Publicado: (2022) -
Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset
por: Sadeghi-Bahmani, Dena, et al.
Publicado: (2022)